Discover 3,617 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,617
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Los Angeles CA, Phoenix AZ, Palo Alto CA, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Fullerton CA, Pasadena CA, Northridge CA, Carlsbad CA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
Immediate Postpartum Glucose Tolerance Testing
for
Gestational Diabetes
Location: Long Beach CA
Sponsor: MemorialCare Health System
Sex: Female
Age: 18+
Code: NCT04199676
Recruiting
Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults
for
Alcohol Consumption, Alcohol Abuse/Dependence
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 21 - 28
Code: NCT06627803
Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
for
Myopia
Location: Fullerton CA, Palo Alto CA, Tucson AZ,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 5 - 11
Code: NCT07095894
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: Loma Linda CA, Phoenix AZ, Salt Lake City UT, Aurora CO,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07085104
Phase 1, Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Location: Los Angeles CA, La Jolla CA, Stanford CA, Seattle WA,
Sponsor: XVIVO Perfusion
Sex: All
Age: 18+
Code: NCT06895070
Recruiting
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Chino CA, Los Angeles CA, Philadelphia PA, Toronto,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06963021
Phase 3, Recruiting
The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
for
Myopia
Location: Fullerton CA, Houston TX, Eutaw AL
Sponsor: National Eye Institute (NEI)
Sex: All
Age: 6 - 14
Code: NCT00000169
Recruiting
AFO Prescription to Optimize Post-Stroke Function
for
Ankle Foot Orthosis (AFO), Stroke Patients,
Location: Downey CA, Houston TX, Jacksonville FL, Charleston SC
Sponsor: University of Texas at Austin
Sex: All
Age: 18+
Code: NCT06692686
Recruiting
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
for
Dry Eye
Location: Newport Beach CA, Memphis TN
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07179055
Phase 2, Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Beverly Hills CA, Denver CO, Seattle WA, St Louis MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase 1, Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Newport Beach CA, McKinney TX, Mesquite TX,